B2 adrenergic receptor (ADRB2) gene variation could explain differences in bronchodilator response among patients with asthma or identify a subgroup of patients with reduced response.

The aim of our research was identified polymorphisms in the ADRB2 gene in Russian asthma pediatric patients (in Perm region).

44 children from 3 to 18 years of age with bronchial asthma were examined. Mild asthma was in 95,5% , moderate asthma -- in 4,5%. Gly16Arg and Gln27Glu mutations of ADRB2 gene were identified by PCR technique.

Results
=======

Gly16Arg mutations of ADRB2 gene was identified in 45,5% and Gln27Glu mutations -- in 27,2% (table [1](#T1){ref-type="table"}).

###### 

The distribution of genotypes of ADRB2 gene in children with asthma

  Variant          Genotipe                                 
  ---------------- ---------- -------- -------- ---- ------ ----
  **rs1042713**    **AA**     **AG**   **GG**               
                                                            
                   \%         n        \%       n    \%     n
                                                            
                   18,1       8        36,4     16   45,5   20
                                                            
  **rs 1042714**   **CC**     **CG**   **GG**               
                                                            
                   36,4       16       36,4     16   27,2   12

There were not correlations between severity of bronchial asthma and ADRB2 gene polymorphisms (Gly16Arg and Gln27Glu mutations). The total IgE level was increased in group with Gly16Arg mutation 565,6±242,6 ME/ml, comparatively group without mutation (255±60,31 ME/ml, p=0,563). We found that asthma exacerbations in children with gene mutations occurs after allergen's exposure in 64% cases. In group without the mutation asthma exacerbations occurs in acute viral respiratory infections in 68% cases.

Thus ADRB2 gene polymorphisms may be associated with clinical features of asthma in children.
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